3 completed, 1 terminated. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow VTX-2337: new trials by email Literature Review of VTX-2337 trials Research Report on VTX-2337
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod - Ovarian Cancer | Phase 1 / Phase 2 | Completed | Ludwig Institute for Cancer Research | 53 | 2015-12-02 | 2022-10-10 |
| Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck VTX-2337, Carboplatin, Cisplatin - Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Completed | Celgene | 195 | 2013-10-14 | 2019-10-29 |
| VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer pegylated liposomal doxorubicin (PLD), VTX-2337, Placebo - Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Completed | Celgene | 297 | 2012-10-31 | 2019-09-26 |
| VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas VTX-2337 plus radiotherapy - Low Grade B Cell Lymphoma | Phase 1 / Phase 2 | Terminated | Celgene | 2 | 2011-07-01 | 2019-09-25 |
Brenner Tumor (1) · Carcinoma, Ovarian Epithelial (1) · Fallopian Tube Neoplasms (1) · Lymphoma (1) · Ovarian Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Celgene (3) · Ludwig Institute for Cancer Research (1)
United States (4) · Switzerland (1)
Amar Patel, MD (3) · Bradley J Monk, MD (1) · Bradley J. Monk, MD (1) · Ezra Cohen, MD (1) · George Coukos, MD, PhD (1) · Robert Ferris, MD, PhD (1)
PMID 24807889, PMID 27810904, PMID 28453702, PMID 29931076, PMID 37407274